Literature DB >> 25298163

Validity of the Swedish SCID and ADDIS diagnostic interviews for substance use disorders: sensitivity and specificity compared with a LEAD golden standard.

Arne Gerdner1, Jenny Kestenberg, Mattias Edvinsson.   

Abstract

OBJECTIVE: The study explores agreement on diagnoses and diagnostic criteria for substance use disorders between two structured assessment interviews, the Structured Clinical Interview for the DSM-IV (SCID) and the Alkohol/Drog Diagnos InStrument (ADDIS). Both interviews are compared with a golden standard (GS), based on a LEAD model (Longitudinal, Expert, All Data).
METHOD: Patients were interviewed concerning substance use problems by trained interviewers using SCID and ADDIS separately and blind to each other's results. SCID and ADDIS interviews were compared with each other, and both were compared with a GS.
RESULTS: Satisfactory agreement exists between SCID and ADDIS on criteria as well as final diagnostic suggestions, although ADDIS tended to propose dependence diagnoses somewhat more often than SCID. Agreement between SCID and GS is moderate. Sensitivity of SCID is satisfactory, as is specificity for lifetime diagnoses, while specificity for current diagnoses is perfect. ADDIS demonstrates substantial to perfect agreement with GS on dependence diagnoses and moderate agreement on abuse diagnoses (both lifetime and current), as well as showing excellent to perfect overall sensitivity and specificity. Both instruments are in almost perfect agreement with the GS on severity ratings.
CONCLUSION: Both ADDIS and SCID can be used to ensure good standards in the diagnostic assessment of substance use disorders (both alcohol and drugs), with and without psychiatric comorbidity. Significant outcomes. Both SCID and ADDIS are in good agreement with the GS based on a LEAD model concerning substance use disorders.

Entities:  

Keywords:  ADDIS; SCID; Sensitivity; Specificity; Substance use disorders; Validity

Mesh:

Year:  2014        PMID: 25298163     DOI: 10.3109/08039488.2014.926987

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  3 in total

1.  Reliability of ADDIS for diagnoses of substance use disorders according to ICD-10, DSM-IV and DSM-5: test-retest and inter-item consistency.

Authors:  Arne Gerdner; Lynn Wickström
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-04-02

Review 2.  Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges.

Authors:  Jonathan D Chevinsky; Thomas A Wadden; Ariana M Chao
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-14       Impact factor: 3.168

3.  Prevalence and comorbidity in a Swedish adolescent community sample - gambling, gaming, substance use, and other psychiatric disorders.

Authors:  Arne Gerdner; Anders Håkansson
Journal:  BMC Psychiatry       Date:  2022-09-06       Impact factor: 4.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.